No Data
No Data
Lilly Collaborates With OpenAI to Discover Novel Medicines to Treat Drug-resistant Bacteria
INDIANAPOLIS, June 25, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced a collaboration with OpenAI that will allow Lilly to leverage OpenAI's generative AI to invent novel antimicrobi
Active Fund Managers Bet These 6 Stocks Will Trade Near All-Time Highs
Active fund managers are making large bets on six already high-performing stocks.The Data: A post on X relayed data from Bank of America research.Magnificent 5 + GLP-1 are overweight by active funds p
Lilly Gains Approval of Lebrikizumab in Canada for Atopic Dermatitis
Express News | Cantor Fitzgerald Reiterates Overweight on Eli Lilly and Co, Maintains $885 Price Target
Eli Lilly and Co Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/26/2024 -2.21% Cantor Fitzgerald $885 → $885 Reiterates Overweight → Overweight 06/25/2024 -2.21% Canto
Novo Nordisk, Eli Lilly Still Top 2 Pharma Stocks: Analyst
No Data
Crefuthope : God's share is not unexpected and stable.